Monthly Archives: January 2012
Stem Cells Reported to Improve Vision
UCLA researchers announce improvement in 2 patients receiving stem cell transplants for retinal eye diseases; macular degeneration and Stargardt's Disease.
Indoco, DSM sign agreement for commercial cooperation for eight APIs
Royal DSM N.V., today announced the signing of an agreement with Indoco Remedies Limited, Mumbai, India, for commercial cooperation for eight Active Pharmaceutical Ingredients (APIs). The alliance came into effect in January 2012.
Circadian’s VGX-100 human antibody improves corneal graft survival
Circadian Technologies Limited announced today the publication of data in the scientific journal, Investigative Ophthalmology & Visual Science (IOVS), showing that VEGF-C expression is markedly up-regulated in corneal graft rejection.
Windows To The Mind
The eyes are the window into the soul - or at least the mind, according to a new paper published in Perspectives on Psychological Science, a journal of the Association for Psychological Science. Measuring the diameter of the pupil, the part of the eye that changes size to let in more light, can show what a person is paying attention to...
Mass. Eye and Ear cornea specialist wins RPB Senior Scientific Investigator Award
Research to Prevent Blindness (RPB) has granted Massachusetts Eye and Ear Infirmary cornea specialist James Chodosh, M.D., M.P.H., a $150,000 Senior Scientific Investigator Award. RPB Senior Scientific Investigator Awards support nationally recognized scientists conducting eye research at medical institutions in the United States.
AMD Update 16: Visualization of Drusen and RPE With New Software Application for Zeiss HD-OCT: A New Aid for Assessing Both Dry and Wet AMD
As noted below, by both Drs. Rosenfeld and Puliafito, this new diagnostic tool will play an important role in assessing and speeding the development of new treatments for both dry and wet AMD that are being researched and brought to the market.
In an announcement on January 20th, Carl Zeiss Meditec said that it had added new dry age-related macular degeneration (Dry AMD) and new glaucoma diagnostic tools for its Cirrus HD-OCT (High Definition Optical Coherence Tomography), and the new software, version 6.0, had received clearance from the US Food and Drug Administration (FDA).
 |
| Zeiss Meditec Cirrus HD-OCT |
"Designed to (Read more...)
A 72-Year-Old Woman With Chronic Pain and Tearing
A 72-year-old woman presents with chronic pain and tearing in one eye. What is your diagnosis?
Medscape Ophthalmology
Medscape Ophthalmology
Researchers Develop Gene Therapy That Could Correct A Common Form Of Blindness
A new gene therapy method developed by University of Florida researchers has the potential to treat a common form of blindness that strikes both youngsters and adults. The technique works by replacing a malfunctioning gene in the eye with a normal working copy that supplies a protein necessary for light-sensitive cells in the eye to function...
An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Status: Not yet recruiting,
Condition Summary: Age-Related Macular Degeneration; Wet Macular Degeneration; Macular Degeneration; Eye Diseases; Retinal Diseases
Experts comment on successful stem cell therapy for blindness
According to a new study published in The Lancet, privately funded and led by UCLA and Advanced Cell Technology researchers, two women suffering a progressive form of blindness have shown improved vision.
Macular Degeneration Improves With Embryonic Stem Cells
Before treatment, the 51-year-old graphic artist was legally blind, unable to read a single letter on a standard eye chart.
Reuters Health Information
Reuters Health Information
Visual Implant and Camera Give Blind Some Vision
Ongoing trials of the Argus II Retinal Prosthesis System (Second Sight Medical Products) show that it returns useful visual perception to patients rendered blind by outer retinal degeneration.
Reuters Health Information
Reuters Health Information
Stem cells show promise in treating blindness
A medical breakthrough was reported Monday in the journal The Lancet wherein the results of a therapy using human embryonic stem cells in two legally blind patients was described.
Montefiore vision experts encourage public to learn more about glaucoma
January is National Glaucoma Awareness Month. Vision experts at Montefiore Medical Center encourage the public to learn more about this disease, which is the leading cause of preventable blindness in the United States.
New gene therapy shows promise against X-linked retinitis pigmentosa
A new gene therapy method developed by University of Florida researchers has the potential to treat a common form of blindness that strikes both youngsters and adults.
Retinitis Pigmentosa In Dogs Cured By Gene Therapy
Members of a University of Pennsylvania research team have shown that they can prevent, or even reverse, a blinding retinal disease, X-linked Retinitis Pigmentosa, or XLRP, in dogs. The disease in humans and dogs is caused by defects in the RPGR gene and results in early, severe and progressive vision loss. It is one of the most common inherited forms of retinal degeneration in man...
RPB awards $220,000 to SUNY Downstate for eye research
Capping SUNY Downstate Medical Center's growth into a major center for eye research, Research to Prevent Blindness (RPB) has awarded SUNY Downstate a four-year challenge grant of $220,000 to spur the development of advanced research into the causes, treatment, and prevention of blinding diseases. Douglas R. Lazzaro, MD, professor and chair of ophthalmology, is the principal investigator.
Stem Cells in Ophthalmology Update 16: Results of First Embryonic Stem Cells in Treatment of Eye Disease Reported in Peer-Reviewed Journal
Two significant events were reported today by Advanced Cell Technology. First, the company said that a peer-reviewed publication of clinical results from its first patients treated at UCLA Jules Stein Eye Institute had been placed online by the UK’s The Lancet. The study reported on the four-month results of a safety study initiated in human patients last July. In that study, one eye of a patient with Stargardt’s macular dystrophy (SMD), and another with the dry form of AMD were given doses of human embryonic stem cell-derived retinal pigment epithelial (RPE) cells.
The second event was the announcement (Read more...)
Stem Cell Treatment For Blindness Shows Promise In Trials
The first published results of trials using cells derived from human embryonic stem cells appear to show they have passed an initial safety hurdle...
Stem Cell Therapy Safe in Macular Degeneration (CME/CE)
(MedPage Today) -- In the first application of its kind, human embryonic stem cells were safely used to treat macular degeneration in two patients, researchers reported.
Subscribe
